Can a common supplement slow lung scarring? new trial targets gene clue
Disease control
Completed
This study tested whether the antioxidant N-acetylcysteine (NAC) can slow lung decline in people with idiopathic pulmonary fibrosis (IPF) who have a specific gene variant (TOLLIP TT). Over 200 participants took NAC or a placebo for 24 months. The goal was to see if NAC delays wor…
Phase: PHASE3 • Sponsor: Fernando J Martinez • Aim: Disease control
Last updated Jun 27, 2026 11:04 UTC